SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-20-211366
Filing Date
2020-08-06
Accepted
2020-08-06 08:05:29
Documents
3
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A d681265d10qa.htm 10-Q/A 23464
2 EX-31.1 d681265dex311.htm EX-31.1 11400
3 EX-31.2 d681265dex312.htm EX-31.2 11402
  Complete submission text file 0001193125-20-211366.txt   47417
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38503 | Film No.: 201079922
SIC: 2834 Pharmaceutical Preparations